|
Market Closed -
Euronext Paris
11:55:00 2026-10-23 am EDT
|
5-day change | 1st Jan Change | ||
| 17.90 EUR | -0.56% |
|
-3.76% | -40.92% |
| Sep. 17 | Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Apr. 22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 311M 348M 287M 260M 487M 33.04B 495M 3.45B 1.37B 17.31B 1.31B 1.28B 54.57B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 263M 294M 243M 220M 412M 27.95B 419M 2.92B 1.16B 14.64B 1.1B 1.08B 46.17B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
12.84% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| BOI | Real-time | |
CBOE
| BOIp | Real-time | |
Börse Stuttgart
| BON | Delayed | |
Deutsche Boerse AG
| BON | Delayed | |
CBOE
| 0DTF | Real-time | |
Boerse Muenchen
| BON | Real-time |
| 1 day | -0.56% | ||
| 1 week | -3.76% | ||
| Current month | -10.50% | ||
| 1 month | -9.60% | ||
| 3 months | -34.43% | ||
| 6 months | -30.35% | ||
| Current year | -40.92% |
| 1 week | 17.45 | 18.6 | |
| 1 month | 16.9 | 20.9 | |
| Current year | 16.9 | 30.95 | |
| 1 year | 16.9 | 32.25 | |
| 3 years | 16.9 | 43.96 | |
| 5 years | 16.9 | 56.5 | |
| 10 years | 16.9 | 92.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 2024-12-31 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 2011-06-30 |
| Director/Board Member | 54 | 2010-03-09 | |
| Director/Board Member | 51 | 2013-05-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/29/23 | Sell | Director | 198,664 | 1.1323% | ||
| 10/29/23 | Sell | Director | 462,964 | 2.6387% | ||
| 10/29/23 | Sell | Director | 4,748 | 0.0271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.56% | -3.76% | -34.19% | -55.25% | 348M | ||
| -2.54% | +1.31% | +55.10% | +120.84% | 1,135B | ||
| -1.42% | +3.23% | +37.07% | +74.26% | 636B | ||
| +0.16% | +0.08% | +25.14% | +97.36% | 505B | ||
| -0.31% | +3.09% | +43.92% | +64.55% | 378B | ||
| -1.34% | -0.47% | +66.63% | +40.56% | 358B | ||
| -0.68% | +2.65% | +22.46% | +51.48% | 295B | ||
| -1.20% | +3.04% | +2.62% | +26.97% | 266B | ||
| -1.79% | +1.57% | +49.97% | +60.87% | 237B | ||
| -0.73% | -0.10% | +29.24% | +101.19% | 193B | ||
| Average | -0.66% | +1.58% | +29.80% | +58.28% | 400.47B | |
| Weighted average by Cap. | -0.26% | +2.66% | +40.99% | +82.12% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 546M 450M 408M 764M 51.83B 776M 5.42B 2.15B 27.16B 2.05B 2.01B 85.61B | 501M 561M 463M 420M 785M 53.27B 798M 5.57B 2.21B 27.91B 2.11B 2.06B 87.99B |
| Net income | 11.34M 12.69M 10.47M 9.49M 17.75M 1.21B 18.05M 126M 49.89M 631M 47.64M 46.63M 1.99B | 32.64M 36.55M 30.16M 27.33M 51.13M 3.47B 51.97M 363M 144M 1.82B 137M 134M 5.73B |
| Net Debt | -49.74M -55.7M -45.95M -41.64M -77.9M -5.29B -79.19M -553M -219M -2.77B -209M -205M -8.73B | -47.86M -53.59M -44.21M -40.06M -74.95M -5.09B -76.19M -532M -211M -2.67B -201M -197M -8.4B |
Employees
2,623
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | €17.90 | -0.56% | 7,191 |
| 26-10-22 | €18.00 | +0.28% | 11,879 |
| 26-10-21 | €17.95 | -0.28% | 10,143 |
| 26-10-20 | €18.00 | -0.83% | 3,156 |
| 26-10-19 | €18.15 | -2.42% | 3,661 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
Select your edition
All financial news and data tailored to specific country editions

















